A Phase 2a, Double-Blind, Placebo-Controlled, Two-Part Study To Investigate the Safety And Efficacy Of Increasing Doses Of DNS-7801 In Parkinson's Disease (PD) Subjects With Motor Fluctuations
Clinical Trial Grant
Administered By
Neurology, Movement Disorders
Awarded By
Dart NeuroScience
Start Date
October 3, 2017
End Date
October 10, 2018
Administered By
Neurology, Movement Disorders
Awarded By
Dart NeuroScience
Start Date
October 3, 2017
End Date
October 10, 2018